U. Ekstrom et al., MUTATIONS IN THE LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE IN SWEDISH FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS - CLINICAL EXPRESSION AND TREATMENT RESPONSE, European journal of clinical investigation, 28(9), 1998, pp. 740-747
Citations number
35
Categorie Soggetti
Medicine, Research & Experimental","Medicine, General & Internal
Background Familial hypercholesterolaemia, an autosomal co-dominant di
sorder caused by defects in the low-density lipoprotein receptor gene,
is strongly associated with premature development of cardiovascular d
isease. Methods In this study, we have applied a gene screening method
in a population of familial hypercholesterolaemia patients in order t
o describe the genetic background of the disease in southern Sweden. T
hese patients were studied with the aim of relating the presence of th
e different mutations to the clinical expression of the disease and to
the response to pharmacological treatment. Results In 16 out of 21 pa
tients, potentially disease-causing low-density lipoprotein receptor g
ene defects were found, including five not previously described altera
tions (C240-->F, C122-->stop, C356-->Y, 785insG, 165delG). No defects
in apolipoprotein B were found. One group of patients (n = 4) carried
the mutation C122-->stop and another group of patients (n = 4) a mutat
ion causing the substitution W66-->G. Patients in the two genotype sub
groups were very similar with respect to lipid levels before treatment
. Conclusion A tendency towards differential susceptibility to treatme
nt with statins was observed for the patient groups, encouraging furth
er comparative studies of heterozygous FH patients.